As mentioned earlier, pro-inflammatory cytokines such as IL-6 and TNF-α are implicated to promote insulin resistance by interfering with the insulin signaling pathway, leading to the pre-clinical manifestation of T2DM (Gregor and Hotamisligil, 2011). The gene discussed is INS; the disease is Insulin resistance.